114 related articles for article (PubMed ID: 19886183)
1. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
[TBL] [Abstract][Full Text] [Related]
2. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
[TBL] [Abstract][Full Text] [Related]
3. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
5. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of metallaproteinase/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury.
Mazanowska O; Kamińska D; Krajewska M; Zabińska M; Kopeć W; Boratyńska M; Chudoba P; Patrzalek D; Klinger M
Transplant Proc; 2011 Oct; 43(8):3000-3. PubMed ID: 21996210
[TBL] [Abstract][Full Text] [Related]
7. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
Nicholson ML; Waller JR; Bicknell GR
Br J Surg; 2002 Jul; 89(7):933-7. PubMed ID: 12081746
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of MMP-1 and MMP-3 produced by mast cells and macrophages in liver fibrogenesis of rat.
Jeong WI; Do SH; Jeong DH; Hong IH; Park JK; Ran KM; Yang HJ; Yuan DW; Kim SB; Cha MS; Jeong KS
Anticancer Res; 2006; 26(5A):3517-26. PubMed ID: 17094476
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation.
Hirt-Minkowski P; Marti HP; Hönger G; Grandgirard D; Leib SL; Amico P; Schaub S
Transpl Immunol; 2014 Jan; 30(1):1-6. PubMed ID: 24291496
[TBL] [Abstract][Full Text] [Related]
10. A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2003; 54(3):171-7. PubMed ID: 14703283
[TBL] [Abstract][Full Text] [Related]
11. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
13. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
Hemmerlein B; Johanns U; Halbfass J; Böttcher T; Heuser M; Radzun HJ; Thelen P
Int J Oncol; 2004 May; 24(5):1069-76. PubMed ID: 15067327
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
Danilewicz M; Wagrowska-Danilewicz M
Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
[TBL] [Abstract][Full Text] [Related]
15. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Fligiel SE; Standiford T; Fligiel HM; Tashkin D; Strieter RM; Warner RL; Johnson KJ; Varani J
Hum Pathol; 2006 Apr; 37(4):422-30. PubMed ID: 16564916
[TBL] [Abstract][Full Text] [Related]
17. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
[TBL] [Abstract][Full Text] [Related]
18. [Expression of MMP-2 and TIMP-1 in renal tissues of patients with chronic active antibody-mediated renal graft rejection].
Wang BY; Yan Q; Zou HQ; Sui WG; Zuo GM; Liang GR; Luo H; Xie SY; Chen HZ; Xie SP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2048-51. PubMed ID: 22200710
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
